CONFIDENTIAL FIRST AMENDMENT TO AMENDED AND RESTATED RESEARCH COLLABORATION AND COMMERCIAL LICENSE AGREEMENTResearch Collaboration and Commercial License Agreement • June 1st, 2017 • Mersana Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJune 1st, 2017 Company IndustryThis First Amendment (the “First Amendment”) to Amended and Restated Research Collaboration and Commercial License Agreement, as amended, made as of this [09] day of March, 2017 (the “First Amendment Effective Date”), is by and between
SECOND AMENDMENT TO AMENDED AND RESTATED RESEARCH COLLABORATION AND COMMERCIAL LICENSE AGREEMENTResearch Collaboration and Commercial License Agreement • August 11th, 2017 • Mersana Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 11th, 2017 Company IndustryThis Second Amendment (the “Second A&R Amendment”) to Amended and Restated Research Collaboration and Commercial License Agreement, as amended, made as of this 2nd day of August, 2017 (the “Second A&R Amendment Effective Date”), is by and between
THIRD AMENDMENT TO AMENDED AND RESTATED RESEARCH COLLABORATION AND COMMERCIAL LICENSE AGREEMENTResearch Collaboration and Commercial License Agreement • November 13th, 2017 • Mersana Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2017 Company IndustryThis Third Amendment (the “Third A&R Amendment”) to the Amended and Restated Research Collaboration and Commercial License Agreement, dated January 29, 2016, as amended from time to time (the “Original Agreement”), made as of this30th day of October, 2017 (the “Third A&R Amendment Effective Date”), is by and between